1.The production and distribution of IL-6 and TNF-alpha in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome.
Katarzyna BASINSKA ; Krzysztof MARYCZ ; Agnieszka SMIESZEK ; Jakub NICPON
Journal of Veterinary Science 2015;16(1):113-120
A main symptom of equine metabolic syndrome (EMS) in ponies is pathological obesity characterized by abnormal accumulation of fat deposits and inflammation. In this study, we analyzed the expression of two pro-inflammatory cytokines, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), in subcutaneous adipose tissue and the correlation with serum concentrations in peripheral blood of Welsh ponies. Based on clinical examination findings, the animals were divided into two groups: ponies affected with EMS (n = 8) and obese ponies (n = 8). The adipose tissue was examined using immunohistochemical analysis while concentrations IL-6 and TNF-alpha were measured using enzyme-linked immunosorbent assays (ELISAs). Additionally, histological characterization of the adipose tissue was performed. The results obtained showed that IL-6 expression in adipose tissue biopsies derived from animals with EMS was enhanced while TNF-alpha levels of both groups were comparable. Compared to the obese ponies, EMS animals also had significantly elevated levels of serum IL-6 and TNF-alpha. Histological analysis revealed macrophage infiltration and fibrosis in adipose tissue preparations from the EMS group. These data suggest that IL-6 may play a key role in the course of EMS in Welsh ponies. Our findings also demonstrated that analysis of pro-inflammatory cytokines levels in serum may serve as an additional tool for diagnosing EMS.
Adipose Tissue/*metabolism
;
Animals
;
Female
;
Horse Diseases/blood/*metabolism
;
Horses
;
Interleukin-6/blood/genetics/*metabolism
;
Male
;
Metabolic Syndrome X/metabolism/*veterinary
;
Tumor Necrosis Factor-alpha/blood/genetics/*metabolism
2.Determination of angiotensin I-converting enzyme activity in equine blood: lack of agreement between methods of analysis.
Maria Fernanda de M COSTA ; Adriana K CARMONA ; Marcio F M ALVES ; Timothy M RYAN ; Helen M DAVIES ; Garry A ANDERSON ; Ron F SLOCOMBE
Journal of Veterinary Science 2011;12(1):21-25
Angiotensin-I converting enzyme (ACE) is a key regulator of blood pressure, electrolytes and fluid homeostasis through conversion of angiotensin I into angiotensin II. Recently, a genetic polymorphism of the ACE gene, which accounts for 47% of the variation of ACE activity in blood, has been advocated as a biomarker of athletic aptitude. Different methods of analysis and determination of ACE activity in plasma have been used in human and equine research without a consensus of a "gold standard" method. Different methods have often been used interchangeably or cited as being comparable in the existing literature; however, the actual agreement between assays has not been investigated. Therefore, in this study, we evaluated the level of agreement between three different assays using equine plasma obtained from 29 horses. Two spectrophotometric assays using Furylacryloyl-phenylalanyl-glycyl-glycine as substrate and one fluorimetric assay utilizing o-aminobenzoic acid-FRK-(Dnp)P-OH were employed. The results revealed that the measurements from the different assays were not in agreement, indicating that the methods should not be used interchangeably for measurement of equine ACE activity. Rather, a single method of analysis should be adopted to achieve comparable results and critical appraisal of the literature is needed when attempting to compare results obtained from different assays.
Animals
;
Enzyme Assays/*methods
;
Female
;
Fluorometry/*methods
;
Horses/blood/genetics/*metabolism
;
Male
;
Oligopeptides/pharmacology
;
Peptidyl-Dipeptidase A/blood/genetics/*metabolism
;
Polymorphism, Genetic
;
Reference Values
;
Spectrophotometry/*methods